Nomura Healthcare Fund Class R DLRHX

Medalist Rating as of | See Nomura Investment Hub
  • NAV / 1-Day Return 26.52  /  −1.71 %
  • Total Assets 751.8M
  • Adj. Expense Ratio
    1.460%
  • Expense Ratio 1.460%
  • Distribution Fee Level Above Average
  • Share Class Type Retirement, Medium
  • Category Health
  • Investment Style Mid Value
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 2.20%
  • Turnover 5%

USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:11 AM GMT+0

Morningstar’s Analysis DLRHX

Will DLRHX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Investors seeking a healthcare vehicle have better options.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Macquarie Healthcare isn’t a compelling source of exposure to its target sector.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DLRHX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 40.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

UCB SA

5.45 38M
Healthcare

Pfizer Inc

4.27 30M
Healthcare

Regeneron Pharmaceuticals Inc

4.12 29M
Healthcare

Eli Lilly and Co

4.10 29M
Healthcare

Gilead Sciences Inc

4.03 28M
Healthcare

AbbVie Inc

3.88 27M
Healthcare

UnitedHealth Group Inc

3.80 27M
Healthcare

Merck & Co Inc

3.64 26M
Healthcare

Elevance Health Inc

3.53 25M
Healthcare

AstraZeneca PLC

3.48 24M
Healthcare

Sponsor Center